|
|
| | As the end of the year quickly draws closer, it feels timely to reflect on what has been a significant year in the life of the VCCC Alliance.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and Education Leads take VCCC Alliance forward
Eleven honorary Research and Education Leads across 10 tumour stream areas will drive excellence in collaboration to improve outcomes for people experiencing cancer, as part of the VCCC Alliance’s Strategy 2024-2029. The positions will amplify world-leading best practice and share learnings with colleagues across the Alliance members and further afield. |
|
|
|
|
Regional cancer workforce education initiative goes national
A regional educational initiative first piloted by the VCCC Alliance in Victoria will now be rolled out nationally, with financial support from the Federal government. The alliance has been awarded $962,276 from the Australian Government’s Cancer Patient Support Program grants to help drive improvements in regional cancer care,
|
|
|
|
|
Victoria can remove regional and metro equity gap
Victoria could be the first jurisdiction in the world to remove the gap in cancer outcomes between regional and metropolitan areas, Professor Grant McArthur AO told the VCCC Alliance 6th annual Consumer Engagement Forum.
|
|
|
|
| Board director Professor Kathryn North AC steps downBoard Chair Professor Sanchia Aranda AM has paid tribute to Murdoch Children’s Research Institute (MCRI) Director, Prof Kathryn North AC, who is stepping down from her position on the VCCC Alliance board after nine years of outstanding service. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
Experts to guide VCCC Alliance Precision Oncology Forum
The VCCC Alliance’s regular Precision Oncology Forum has drawn together a stellar cast of experts to advise on topics going forward. Seven individuals from across VCCC Alliance members have joined an Expert Reference Group for the forum, which is co-chaired by Dr Joep Vissers, Curation Scientist Team Leader, the University of Melbourne, and Dr Huiling Xu Senior Research Fellow, Peter MacCallum Cancer Centre. |
|
|
|
|
Lymphoma researcher A/Prof Eliza Hawkes wins VCCC Alliance 2024 Tony Burgess Medal
Associate Professor Eliza Hawkes, Lymphoma Lead and oncologist at Austin Health, and researcher at the Olivia Newton-John Cancer Research Institute, received the Tony Burgess Medal at the 2024 VCCC Alliance Awards. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Does doctor always know best?When you are diagnosed with cancer, it is not unusual to feel powerless, perplexed or even overwhelmed about your treatment options. I decided to be a co-pilot, not a passenger, in tackling my health challenge. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
EOI: Health Equity Advisory Group Applications close 5.00pm, Sunday 26 January 2025 The VCCC Alliance is calling for health professionals, consumers, researchers and staff from not-for-profit organisations, health services, and advocacy organisations who are interested and passionate about health equity to join the VCCC Alliance Health Equity Advisory Group. Learn more and apply › |
|
|
Centre for Cancer Education |
|
|
New ways to treat hepatitis B and prevent primary liver cancer
CATEGORY: WEBINAR
DURATION: 60 MINUTES
Clinicians at St Vincent's Health are partnering with laboratory researchers at Peter MacCallum Cancer Centre, The Peter Doherty Institute and University of Melbourne to devise new ways of disrupting hepatitis B virus (HBV), using CRISPR-Cas 13 technology. In this session, you will hear how this new approach has so far been successful in markedly reducing levels of HBV antigens S and E, and of intact HBV particles both in cell lines and infected primary liver cells in experimental models.
|
|
|
|
|
Disease Assessments in Clinical Trials Online Course
CATEGORY: COURSE
DURATION: 3 HOURS
Evaluating the alteration in tumour size is a crucial aspect of assessing the effectiveness of cancer treatments in clinical settings. Both tumour reduction (objective response) and the duration until disease progression occurs are significant endpoints in cancer clinical trials. Join our panel of experts who will guide you through the fundamentals of disease assessment in clinical trials, ensuring you achieve meaningful endpoints from the outset. |
|
| |
|
|
|
|
|
|
|
|
|
|
|
Innovative solutions for patient and hospital accommodation
CATEGORY: WEBINARDURATION: 1 HOUR
MediStays is Australia's health, medical and disability accommodation platform. The service connects Australians and their families with accommodation options to support a hospital visit or treatment-related stay. Be it for patients staying near a hospital, a healthcare professional discharging a patient, or an organisation enhancing capacity with virtual wards, MediStays offers a range of innovative solutions.
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| 4 February 2025
Monday Lunch Live World Cancer Day SAVE THE DATE |
|
| | 3 March 2025
Monday Lunch Live International Women’s Day SAVE THE DATE |
|
|
|
|
|
|
|
|
|
|
|
|
Click here to subscribe to our weekly newsletter and be first to hear about upcoming events and opportunities. |
|
|
|
|
| 11
Education and training events |
|
|
|
|
|
|
|
|
|
|
|
| 554
Education and training event attendees |
|
|
|
|
|
|
|
|
|
|
|
|
|
